Table 3:

Secondary outcomes

Measure	Data source and sample	Value	Change from baseline (95% CI)
Treatment rates
Hypertension treatment rate in month 6, n per month	Routine MOH data	197 patients	See Figure 3
Diabetes treatment rate in month 6, n per month	Routine MOH data	108 patients	See Figure 3
Disease control a
Blood pressure control (<130/80 mmHg) among patients with hypertension, %	Routine MOH data merged with electronic monitoring tool data	50.6%	n/a
Glycemic control (FBG <115 mg/dl or RBG <160 mg/dl) among patients with diabetes, %	Routine MOH data merged with electronic monitoring tool data	41.0%	n/a
Adoption
Facilities enrolling ≥1 patient, %	Routine MOH data from 10 facilities	100%	n/a
Fidelity
Health worker training strategy: Health workers attending all trainings, n per district	Training attendance records	20 health workers per district	n/a
Team-based care strategy: Facilities conducting monthly coordination meetings, %a	Monthly assessments in n=10 facilities	10%	−10% (−26% to 15%)
Team-based care strategy: Prescriptions by non-physician health worker, %	Routine MOH data from 1,341 total visits during pilot	57%	n/a
Strategy to improve access: Availability of core medications, %b	Monthly assessments in n=10 facilities	81%	+21% (2% to 40%)
Strategy to improve access: Availability of core diagnostics, %b	Monthly assessments in n=10 facilities	82%	−5.0% (−25% to 15%)
Fidelity to electronic monitoring tool strategy: Visits captured in electronic monitoring tools (either DHIS2 or digitized chart data), %	Comparing routine MOH data with study data from electronic monitoring tools	7.6%	n/a
Sustainability c
Leadership support, mean	Surveys among n=20 MOH participants	5.0	n/a
Adequate staff to achieve goals, mean	Surveys among n=20 MOH participants	5.1	n/a
Protocol easy for clinicians to use, mean	Surveys among n=20 MOH participants	5.5	n/a
Integrated into MOH operations, mean	Surveys among n=20 MOH participants	5.4	n/a
Defined roles and responsibilities, mean	Surveys among n=20 MOH participants	5.7	n/a
Ongoing support, feedback, and training, mean	Surveys among n=20 MOH participants	4.7	n/a
Usability d
DHIS2 system	Surveys among n=10 MOH participants	67.7	n/a
Paper-based digitization system	Surveys among n=8 MOH participants	80.6	n/a

Abbreviations: DHIS2, District Health Information System. FBG, Fasting blood glucose. n/a, not applicable. RBG, Random blood glucose.

^aDisease control was only calculated among the subsample of 7.6% of patients whose visits were captured in the electronic monitoring tools (either DHIS2 or digitized chart data)

^bCalculated as the mean monthly proportion across clinics over the 6-month pilot period. Core medications include: enalapril, losartan, hydrochlorothiazide, metformin, and glimepiride/glibenclamide. Core diagnostics include functioning glucometer, glucose test strips, and digital blood pressure monitor

^cSelect questions from the Program Sustainability Assessment Tool (PSAT)³³ and Clinical Sustainability Assessment Tools (CSAT)³⁴ are assessed on a scale of 1 to 7 with higher scores representing a greater degree of agreement.

^dThe System Usability Scale^36,37 is assessed on a scale of 0 to 100 with higher scores representing a greater degree of usability.